Repository logo
 

Opposing effects on the cell cycle of T lymphocytes by Fbxo7 via Cdk6 and p27.

Published version
Peer-reviewed

Type

Article

Change log

Authors

Patel, Shachi P 
Randle, Suzanne J 
Gibbs, Sarah 

Abstract

G1 phase cell cycle proteins, such as cyclin-dependent kinase 6 (Cdk6) and its activating partners, the D-type cyclins, are important regulators of T-cell development and function. An F-box protein, called F-box only protein 7 (Fbxo7), acts as a cell cycle regulator by enhancing cyclin D-Cdk6 complex formation and stabilising levels of p27, a cyclin-dependent kinase inhibitor. We generated a murine model of reduced Fbxo7 expression to test its physiological role in multiple tissues and found that these mice displayed a pronounced thymic hypoplasia. Further analysis revealed that Fbxo7 differentially affected proliferation and apoptosis of thymocytes at various stages of differentiation in the thymus and also mature T-cell function and proliferation in the periphery. Paradoxically, Fbxo7-deficient immature thymocytes failed to undergo expansion in the thymus due to a lack of Cdk6 activity, while mature T cells showed enhanced proliferative capacity upon T-cell receptor engagement due to reduced p27 levels. Our studies reveal differential cell cycle regulation by Fbxo7 at different stages in T-cell development.

Description

Keywords

Cdk6, Cell cycle, Fbxo7, T-cell development, p27, Animals, Apoptosis, CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes, Cell Cycle, Cell Differentiation, Cell Proliferation, Cyclin-Dependent Kinase 6, Cyclin-Dependent Kinase Inhibitor p27, Down-Regulation, F-Box Proteins, Female, Gene Deletion, Lymphocyte Activation, Male, Mice, Inbred C57BL, Mutation, T-Lymphocytes, Thymus Gland

Journal Title

Cell Mol Life Sci

Conference Name

Journal ISSN

1420-682X
1420-9071

Volume Title

74

Publisher

Springer Science and Business Media LLC
Sponsorship
Biotechnology and Biological Sciences Research Council (BB/J007846/1)
This work was supported by the University of Cambridge, Department of Pathology Nina King studentship and the Biotechnology and Biological Sciences Research Council (BB/J007846/1), and the Cambridge Fund for the Prevention of Disease.